medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2018, Number 4

<< Back Next >>

Rev Mex Oftalmol 2018; 92 (4)

Autoimmune retinitis: Report of three cases

Jones-Gazmuri A, Díaz-Aljaro I, Zacharias-Santamaría S

Language: Spanish
References: 13
Page: 214-219
PDF size: 687.38 Kb.


ABSTRACT

Autoimmune retinitis comprises a spectrum of diseases that share clinical features and pathophysiology which focuses on the presence of retinal antibodies that produces panretinal degeneration. The clinical picture is characterized by progressive, painless loss of visual acuity associated with photopsias, entopsias, nyctalopia, being the fundus many times normal. The history of neoplastic disease becomes important in relation to the diagnosis, treatment and prognosis, when suspecting this entity. It is necessary to rely on the Goldman visual field, macula OCT, electroretinography and retinal antibodies to confirm the diagnosis. This disease represents a real challenge for the ophthalmologist given the absence of standardized diagnostic criteria. The purpose of this paper is to describe 3 cases of autoimmune retinitis who consulted in Andes Ophthalmological Foundation and a brief review of the disease.


REFERENCES

  1. Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathyand antiretinal antibodies: A review. Retina. 2014;34:827-45.

  2. Braithwaite T, Holder GE, Lee RW, et al. Diagnostic fea-tures of the autoimmune retinopathies. Autoimmun Rev.2014;13:534-8.

  3. Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, et al. Fre-quency of anti-retinal antibodies in normal human serum. JNeuroophthalmol. 2008;28:5-11.

  4. Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: Areview and summary. Semin Immunopathol. 2008;30:127-34.

  5. Grange L, Dalal M, Nussenblatt RB, et al. Autoimmune retino-pathy. Am J Ophthalmol. 2014;157:266-72.

  6. Ohguro H, Yokoi Y, Ohguro I, et al. Clinical and immunologicaspects of cancer-associated retinopathy. Am J Ophthalmol.2004;137:1117-9.

  7. Chan JW. Paraneoplastic retinopathies and optic neuropathies.Surv Ophthalmol. 2003;48:12-38.

  8. Audo I, Robson AG, Holder GE, et al. The negative ERG: Clinicalphenotypes and disease mechanisms of inner retinal dysfunc-tion. Surv Ophthalmol. 2008;53:16-40.

  9. Lima LH, Greenberg JP, Greenstein VC, et al. Hyperautofluores-cent ring in autoimmune retinopathy. Retina. 2012;32:1385-94.

  10. Abazari A, Allam SS, Adamus G, et al. Optical coherence tomo-graphy findings in autoimmune retinopathy. Am J Ophthalmol.2012;153:750-6.

  11. Pepple KL, Cusick M, Jaffe GJ, et al. SD-OCT and auto-fluorescence characteristics of autoimmune retinopathy. Br JOphthalmol. 2013;97:139-44.

  12. Chan CC, Palestine AG, Nussenblatt RB, et al. Anti-retinalauto-antibodies in Vogt-Koyanagi-Harada syndrome: Beh-cet’s disease, and sympathetic ophthalmia. Ophthalmology.1985;92:1025-8.

  13. Comlekoglu DU, Thompson IA, Sen HN. Autoimmune retino-pathy. Curr Opin Ophthalmol. 2013;24:598-605.




2020     |     www.medigraphic.com